Seeing Is Believing
Currently out of the existing stock ratings of Daniel Grosslight, 101 are a BUY (56.74%), 70 are a HOLD (39.33%), 7 are a SELL (3.93%).
Analyst Daniel Grosslight, currently employed at CITI, carries an average stock price target met ratio of 57.21% that have a potential upside of 25.53% achieved within 138 days.
Daniel Grosslight’s has documented 355 price targets and ratings displayed on 25 stocks. The coverage is on Healthcare, Financial Services, Consumer Defensive, Consumer Cyclical, Communication Services sectors.
Most recent stock forecast was given on HIMS, Hims Hers Health at 06-Mar-2025.
Analyst best performing recommendations are on AGL (AGILON HEALTH).
The best stock recommendation documented was for AGL (AGILON HEALTH) at 11/13/2024. The price target of $1.75 was fulfilled within 1 day with a profit of $0.13 (6.91%) receiving and performance score of 69.15.
Average potential price target upside
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date
Price targets met ratio
Average potential upside
Average Time (Days) For PT To Be Met
Performance score
Hold
$27.75
2 years 6 months 14 days ago
(20-Sep-2022)
6/7 (85.71%)
$5.58 (25.17%)
151
Hold
$27.75
$0.26 (0.95%)
$26
2 years 6 months 14 days ago
(20-Sep-2022)
1/2 (50%)
$2.62 (10.43%)
125
Hold
$27.75
$0.26 (0.95%)
$18
2 years 6 months 27 days ago
(07-Sep-2022)
1/2 (50%)
$4.77 (20.76%)
534
Hold
$27.75
$0.26 (0.95%)
$26
2 years 10 months 3 days ago
(31-May-2022)
1/2 (50%)
$5.42 (24.27%)
181
Hold
$21
3 years 16 days ago
(18-Mar-2022)
4/4 (100%)
$6.64 (46.24%)
315
Which stock is Daniel Grosslight is most bullish on?
Which stock is Daniel Grosslight is most reserved on?
What Year was the first public recommendation made by Daniel Grosslight?